Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Xeris Biopharma Holdings Inc (XERIS) is a biopharmaceutical company that develops and commercializes innovative, ready-to-use therapeutic medicine. It utilizes XeriSol and XeriJect proprietary technology platforms for its product development. The company’s products include glucagon injection to target severe hypoglycemia; dichlorphenamide for primary periodic paralysis; levoketoconazole to treat endogenous Cushing's syndrome; and levothyroxine for hypothyroidism. Its brands comprise Gvoke, Gvoke HypoPen, Keveyis, XerisCareConnection, Recorlev, Ogluo and Xeris Pharmaceuticals. The company operates through its subsidiaries in Australia, the US, Ireland and Sweden. XERIS is headquartered in Chicago, Illinois, the US.
Headquarters
United States of America
Address
Suite 1300, 1375 West Fulton Street, Chicago, Illinois, 60607
Website
www.xerispharma.com
Telephone
1 302 6587581
No of Employees
435
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
XERS (NASD)
Revenue (2024)
$291.8M
43.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
101%
(2024 vs 2023)
Market Cap*
$1.5B
Net Profit Margin (2024)
XYZ
100.7%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Brands |
|---|---|
| Glucagon Injection: Severe Hypoglycemia | Gvoke |
| Dichlorphenamide: Primary Periodic Paralysis | Gvoke HypoPen |
| Levoketoconazole: Endogenous Cushing's Syndrome | XeriSol |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Xeris Biopharma Holdings Inc | Teva Pharmaceutical Industries Ltd | Torrent Pharmaceuticals Ltd | Zealand Pharma AS | Corcept Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Israel | India | Denmark | United States of America |
| City | Chicago | Tel Aviv | Ahmedabad | Soeborg | Redwood City |
| State/Province | Illinois | Tel Aviv | Gujarat | - | California |
| No. of Employees | 435 | 31,173 | 17,320 | 544 | 730 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Shannon | Chairman; Chief Executive Officer | Executive Board | 2026 | - |
| Steven M. Pieper | Chief Financial Officer | Senior Management | 2021 | 48 |
| Kevin McCulloch | President; Chief Operating Officer | Senior Management | 2021 | 62 |
| Beth P. Hecht | Chief Legal Officer; Secretary | Senior Management | 2021 | 61 |
| Anh Nguyen | Chief Medical Officer | Senior Management | 2025 | 50 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer